No adverse effects on embryo-fetal progress were observed in pregnant rabbits taken care of orally with doses nearly one hundred mg/kg/working day elafibranor, which manufactured systemic exposures (combined AUC for elafibranor and GFT1007) over the period of organogenesis that were lower than the human exposure. Administration of 300 mg/kg/working day https://johne196ufq4.wikiworldstock.com/user